Myoton Pro is a novel medical diagnostic device for in vivo non-invasive measurement of tone and biomechanical properties of the skeletal muscles.

Myoton Pro device uses the accelerometer based sensing of muscle oscillation and computer processing to obtain objective information on muscle tone, elasticity, stiffness.

The measurement process is painless, non-invasive, quick and precise. Myoton Pro is portable and intuitively easy to operate, featuring automated smart assistance system to ensure minimize the effect of measurers hand coordination capabilities and hand tremor. It can measure each separate muscle, different regions of the same muscle as well as tendon and other soft tissues.

Myoton Pro enable Physiotherapists and Generalist Physicians involved in muscle assessment to access new data – tone, stiffness and elasticity – to more accurately diagnose muscle condition and properties.

Myoton Pro can be used to observe the sufficiency and efficacy of procedures and get an objective assessment. This serves to optimize the training program and motivate patients through feedback. Treatment efficacy, so far evaluated only by patients subjective opinion, can be objectively compared with population norms.

Myoton AS was established in 1999 as a spin-off of Tartu University. The founder and main visionary of Müomeetria has been Dr. habil. biol. Arved Vain, who has devoted most of his professional career to researching and developing solutions that could have positive impact on detecting and treating muscle and other soft tissue pathologies.

Years of R&D and prototyping have lead to the discovery revolutionary Myoton Pro technology that holds the promise of replacing or complementing the existing muscle assessment methods and technologies.

Myoton AS is headquartered in Tallinn, with offices also in Tartu, Estonia. The Company works closely with Tartu University’s University’s institute of Exercise Biology and Physiotherapy.

The Company has successfully applied for various R&D grants, including 1,1 mil EUR Eurostars grant and 400 000 EUR European Space Agency’s PECS program grant.

Myoton technology and myometric method is patented in the EU, US, and Japan.